Zhang, X., Huang, X., Xu, J., Li, E., Lao, M., Tang, T., . . . Liang, T. (2021). NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Nature Communications, 12(1), 1. https://doi.org/10.1038/s41467-021-24769-3
Chicago Style (17th ed.) CitationZhang, Xiaozhen, et al. "NEK2 Inhibition Triggers Anti-pancreatic Cancer Immunity by Targeting PD-L1." Nature Communications 12, no. 1 (2021): 1. https://doi.org/10.1038/s41467-021-24769-3.
MLA (9th ed.) CitationZhang, Xiaozhen, et al. "NEK2 Inhibition Triggers Anti-pancreatic Cancer Immunity by Targeting PD-L1." Nature Communications, vol. 12, no. 1, 2021, p. 1, https://doi.org/10.1038/s41467-021-24769-3.
Warning: These citations may not always be 100% accurate.